$0.53
-0.10 (-15.37%)
Open$0.62
Previous Close$0.63
Day High$0.62
Day Low$0.52
52W High$52.50
52W Low$0.56
Volume—
Avg Volume336.0K
Market Cap2.21M
P/E Ratio—
EPS$-25.66
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 398.2K | 400.3K | 406.3K |
| Net Income | -29,112 | -35,289 | -31,464 |
| Profit Margin | -7.3% | -8.8% | -7.7% |
| EBITDA | -48,158 | -49,842 | -45,919 |
| Free Cash Flow | -34,661 | -49,903 | -42,011 |
| Rev Growth | +16.9% | +4.6% | -8.7% |
| Debt/Equity | 0.13 | 0.15 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |